In your stateConnecticut
In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.
Economic Impact In Your State: Connecticut
$9B
Total output supported by biophamaceutical sector
$477,065
Total output supported by biophamaceutical sector
35,433
Total Jobs
8,963
Direct Jobs
Clinical Trials in Your State: Connecticut
581
TOTAL CLINICAL TRIALS
$145.2 million
INVESTED IN CLINICAL TRIALS
9,582
TOTAL ECONOMIC IMPACT OF CLINICAL TRIAL INVESTMENTS
$374 million
INVESTED IN CLINICAL TRIALS
Programs and Initiatives in Your State: Connecticut
State programs and initiatives to promote biopharmaceutical industry development
- ACCELERATING INNOVATION, COMMERCIALIZATION & ENTREPRENEURIAL DEVELOPMENT
BUILDING RESEARCH CAPACITY AND/OR R&D INFRASTRUCTURE
ECONOMIC INNOVATION INCENTIVES
STEM EDUCATION & WORKFORCE DEVELOPMENT
TARGETED STRATEGIES
VENTURE FINANCING